Skip to main content

FDA files motion to delay Endo litigation, again

The pharmaceutical company is objecting to an FDA policy regarding bulk compounding.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.